Skip to main content
Clinical Journal of the American Society of Nephrology : CJASN logoLink to Clinical Journal of the American Society of Nephrology : CJASN
. 2019 Mar 22;14(5):750. doi: 10.2215/CJN.02630319

Correction

PMCID: PMC6500952  PMID: 30902801

Nishank Jain and Robert F. Reilly: Clinical Pharmacology of Oral Anticoagulants in Patients with Kidney Disease. Clin J Am Soc Nephrol 14: 278–287, 2019.

Due to author error, a correction has been issued for the above referenced article. The text below was incorrectly worded:

“With serum creatinine ≥1.5 mg/dl, age ≥80 years old, or body weight ≤60 kg, a reduced dose of 2.5 mg twice daily is recommended (48).”

The text should have been worded as follows:

The package insert recommends a reduced dose of 2.5 mg twice daily in patients with at least two of the following three clinical characteristics: serum creatinine ≥1.5 mg/dl, age ≥80 years or body weight ≤60 kg.

Footnotes

Published online ahead of print. Publication date available at www.cjasn.org.


Articles from Clinical Journal of the American Society of Nephrology : CJASN are provided here courtesy of American Society of Nephrology

RESOURCES